MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells

Yan,Yihe; Liang,Zhihai; Du,Qiang; Yang,Muqing; Geller,David  A.

doi:10.3892/or.2016.4864

MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells

Authors:
- Yihe Yan
- Zhihai Liang
- Qiang Du
- Muqing Yang
- David A. Geller
View Affiliations

Affiliations: Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA
Published online on: June 9, 2016 https://doi.org/10.3892/or.2016.4864
Pages: 633-640
Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Interferon regulatory factor-1 (IRF-1) is a tumor-suppressor gene induced by interferon-γ (IFNγ) and plays an important role in the cell death of hepatocellular carcinoma (HCC). HCC tumors evade death in part by downregulating IRF-1 expression, yet the molecular mechanisms accounting for IRF-1 suppression in HCC have not yet been characterized. Previous studies have shown that microRNA-23a (miR-23a) can suppress apoptosis by targeting IRF-1. Therefore, we hypothesized that miR-23a promotes HCC growth by downregulating IRF-1. For the in vivo studies, 7 cases of resected HCC and adjacent liver samples were analyzed. For the in vitro studies, IRF-1 mRNA and protein were examined in HepG2 and Huh-7 HCC cells after IFNγ stimulation by real-time PCR and western blotting, respectively. To determine the role of miR-23a in regulating IRF-1, HepG2 cells were transfected with an miR-23a mimic or inhibitor, and IRF-1 expression was examined. Binding of miR-23a was assessed by cloning the 528-bp human IRF-1 3'-untranslated region (3'UTR) into luciferase reporter plasmid pMIR-IRF-1-3'UTR. The results showed that IRF-1 mRNA expression was downregulated in the human HCC tumor tissues compared to that in the adjacent background liver tissues. IFNγ-induced IRF-1 protein was less in the HepG2 tumor cells compared to that in the primary human hepatocytes. miR-23a expression was inversely correlated with IRF-1, and addition of the miR-23a inhibitor increased basal IRF-1 mRNA and protein. Likewise, the miR-23a mimic downregulated IFNγ-induced IRF-1 protein expression, while the miR-23a inhibitor increased IRF-1. Furthermore, the miR-23a mimic repressed IRF-1-3'UTR reporter activity, while the miR-23a inhibitor increased the reporter activity. These results demonstrated that IRF-1 expression is downregulated in human HCC tumors compared to that noted in the background liver. miR-23a downregulates the expression of IRF-1 in HCC cells, and the IRF-1 3'UTR has an miR‑23a binding site that binds miR-23a and decreases reporter activity. These findings suggest that the targeting of IRF-1 by miR-23a may be the molecular basis for IRF-1 downregulation in HCC and provide new insight into the regulation of HCC by miRNAs.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Tamura T, Yanai H, Savitsky D and Taniguchi T: The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol. 26:535–584. 2008. View Article : Google Scholar : PubMed/NCBI
3	Connett JM, Hunt SR, Hickerson SM, Wu SJ and Doherty GM: Localization of IFN-gamma-activated Stat1 and IFN regulatory factors 1 and 2 in breast cancer cells. J Interferon Cytokine Res. 23:621–630. 2003. View Article : Google Scholar : PubMed/NCBI
4	Yim JH, Ro SH, Lowney JK, Wu SJ, Connett J and Doherty GM: The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines. J Interferon Cytokine Res. 23:501–511. 2003. View Article : Google Scholar : PubMed/NCBI
5	Kim PK, Armstrong M, Liu Y, Yan P, Bucher B, Zuckerbraun BS, Gambotto A, Billiar TR and Yim JH: IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo. Oncogene. 23:1125–1135. 2004. View Article : Google Scholar : PubMed/NCBI
6	Stang MT, Armstrong MJ, Watson GA, Sung KY, Liu Y, Ren B and Yim JH: Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells. Oncogene. 26:6420–6430. 2007. View Article : Google Scholar : PubMed/NCBI
7	Gao J, Senthil M, Ren B, Yan J, Xing Q, Yu J, Zhang L and Yim JH: IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells. Cell Death Differ. 17:699–709. 2010. View Article : Google Scholar
8	Armstrong MJ, Stang MT, Liu Y, Yan J, Pizzoferrato E and Yim JH: IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition. Cancer Biol Ther. 16:1029–1041. 2015. View Article : Google Scholar :
9	Li P, Du Q, Cao Z, Guo Z, Evankovich J, Yan W, Chang Y, Shao L, Stolz DB, Tsung A, et al: Interferon-γ induces autophagy with growth inhibition and cell death in human hepatocellular carcinoma (HCC) cells through interferon-regulatory factor-1 (IRF-1). Cancer Lett. 314:213–222. 2012. View Article : Google Scholar
10	Yanai H, Negishi H and Taniguchi T: The IRF family of transcription factors: Inception, impact and implications in oncogenesis. Oncoimmunology. 1:1376–1386. 2012. View Article : Google Scholar : PubMed/NCBI
11	Esmat G, El-Bendary M, Zakarya S, Ela MA and Zalata K: Role of Helicobacter pylori in patients with HCV-related chronic hepatitis and cirrhosis with or without hepatocellular carcinoma: Possible association with disease progression. J Viral Hepat. 19:473–479. 2012. View Article : Google Scholar : PubMed/NCBI
12	Yi Y, Wu H, Gao Q, He HW, Li YW, Cai XY, Wang JX, Zhou J, Cheng YF, Jin JJ, et al: Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC. Ann Surg Oncol. 20:267–276. 2013. View Article : Google Scholar
13	Carthew RW and Sontheimer EJ: Origins and mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009. View Article : Google Scholar : PubMed/NCBI
14	Lujambio A and Lowe SW: The microcosmos of cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
15	Otsuka M, Kishikawa T, Yoshikawa T, Ohno M, Takata A, Shibata C and Koike K: The role of microRNAs in hepato-carcinogenesis: Current knowledge and future prospects. J Gastroenterol. 49:173–184. 2014. View Article : Google Scholar
16	D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, Silvestris N and Cascinu S: The role of micro-RNAs in hepatocellular carcinoma: From molecular biology to treatment. Molecules. 19:6393–6406. 2014. View Article : Google Scholar : PubMed/NCBI
17	Bai Y, Xue Y, Xie X, Yu T, Zhu Y, Ge Q and Lu Z: The RNA expression signature of the HepG2 cell line as determined by the integrated analysis of miRNA and mRNA expression profiles. Gene. 548:91–100. 2014. View Article : Google Scholar : PubMed/NCBI
18	He XX, Kuang SZ, Liao JZ, Xu CR, Chang Y, Wu YL, Gong J, Tian DA, Guo AY and Lin JS: The regulation of microRNA expression by DNA methylation in hepatocellular carcinoma. Mol Biosyst. 11:532–539. 2015. View Article : Google Scholar
19	Huang S, He X, Ding J, Liang L, Zhao Y, Zhang Z, Yao X, Pan Z, Zhang P, Li J, et al: Upregulation of miR-23a~27a~24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells. Int J Cancer. 123:972–978. 2008. View Article : Google Scholar : PubMed/NCBI
20	Nazarov PV, Reinsbach SE, Muller A, Nicot N, Philippidou D, Vallar L and Kreis S: Interplay of microRNAs, transcription factors and target genes: Linking dynamic expression changes to function. Nucleic Acids Res. 41:2817–2831. 2013. View Article : Google Scholar : PubMed/NCBI
21	Liu X, Ru J, Zhang J, Zhu LH, Liu M, Li X and Tang H: miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells. PLoS One. 8:e647072013. View Article : Google Scholar : PubMed/NCBI
22	Ru J, Sun H, Fan H, Wang C, Li Y, Liu M and Tang H: MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1. PLoS One. 9:e1140212014. View Article : Google Scholar : PubMed/NCBI
23	Shao L, Guo Z and Geller DA: Transcriptional suppression of cytokine-induced iNOS gene expression by IL-13 through IRF-1/ISRE signaling. Biochem Biophys Res Commun. 362:582–586. 2007. View Article : Google Scholar : PubMed/NCBI
24	Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M and Taniguchi T: Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature. 382:816–818. 1996. View Article : Google Scholar : PubMed/NCBI
25	Chen FF, Jiang G, Xu K and Zheng JN: Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis. Oncol Lett. 5:417–423. 2013.PubMed/NCBI
26	Armstrong MJ, Stang MT, Liu Y, Gao J, Ren B, Zuckerbraun BS, Mahidhara RS, Xing Q, Pizzoferrato E and Yim JH: Interferon regulatory factor 1 (IRF-1) induces p21^WAF1/CIP1 dependent cell cycle arrest and p21^WAF1/CIP1 independent modulation of survivin in cancer cells. Cancer Lett. 319:56–65. 2012. View Article : Google Scholar
27	Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T and Tanaka N: Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene. 15:1275–1281. 1997. View Article : Google Scholar : PubMed/NCBI
28	Wang B, Hsu SH, Frankel W, Ghoshal K and Jacob ST: Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha. Hepatology. 56:186–197. 2012. View Article : Google Scholar : PubMed/NCBI
29	Wang N, Zhu M, Tsao SW, Man K, Zhang Z and Feng Y: MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma. Mol Cancer. 12:1192013. View Article : Google Scholar : PubMed/NCBI
30	Zhong X, Coukos G and Zhang L: miRNAs in human cancer. Methods Mol Biol. 822:295–306. 2012. View Article : Google Scholar
31	Yuan L, Zhou C, Lu Y, Hong M, Zhang Z, Zhang Z, Chang Y, Zhang C and Li X: IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1. Cancer Lett. 359:136–147. 2015. View Article : Google Scholar : PubMed/NCBI
32	Li Z, Chen B, Feng M, Ouyang H, Zheng M, Ye Q, Nie Q and Zhang X: MicroRNA-23b promotes avian leukosis virus subgroup J (ALV-J) replication by targeting IRF1. Sci Rep. 5:102942015. View Article : Google Scholar : PubMed/NCBI
33	Mao L, Zhang Y, Mo W, Yu Y and Lu H: BANF1is downregulated by IRF1-regulated microRNA-203 in cervical cancer. PLoS One. 10:e01170352015. View Article : Google Scholar